S
CME icon

SignatureFD’s CME Group CME Stock Holding History

SignatureFD’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Buy
6,584
+28
+0.4% +$8.32K 0.03% 239
2025
Q4 		$1.79M Buy
6,556
+239
+4% +$64.9K 0.03% 239
2025
Q3 		$1.71M Sell
6,317
-12
-0.2% -$3.27K 0.03% 246
2025
Q2 		$1.74M Buy
6,329
+871
+16% +$237K 0.03% 228
2025
Q1 		$1.45M Buy
5,458
+204
+4% +$50.3K 0.03% 250
2024
Q4 		$1.22M Buy
5,254
+457
+10% +$105K 0.02% 283
2024
Q3 		$1.06M Sell
4,797
-11
-0.2% -$2.28K 0.02% 317
2024
Q2 		$945K Sell
4,808
-328
-6% -$67.8K 0.02% 326
2024
Q1 		$1.11M Sell
5,136
-258
-5% -$54.2K 0.02% 282
2023
Q4 		$1.14M Buy
5,394
+392
+8% +$83.6K 0.03% 253
2023
Q3 		$1M Buy
5,002
+525
+12% +$104K 0.03% 255
2023
Q2 		$830K Sell
4,477
-497
-10% -$91.8K 0.02% 297
2023
Q1 		$953K Buy
4,974
+1,325
+36% +$240K 0.03% 250
2022
Q4 		$614K Buy
3,649
+179
+5% +$31.1K 0.02% 355
2022
Q3 		$615K Buy
3,470
+451
+15% +$89.1K 0.02% 318
2022
Q2 		$618K Buy
3,019
+232
+8% +$49.2K 0.02% 314
2022
Q1 		$663K Buy
2,787
+419
+18% +$98.4K 0.02% 311
2021
Q4 		$541K Buy
2,368
+147
+7% +$32.3K 0.02% 365
2021
Q3 		$430K Buy
2,221
+247
+13% +$50K 0.01% 424
2021
Q2 		$420K Buy
1,974
+377
+24% +$79.6K 0.02% 412
2021
Q1 		$326K Buy
1,597
+268
+20% +$52.8K 0.01% 425
2020
Q4 		$242K Sell
1,329
-117
-8% -$19.9K 0.01% 475
2020
Q3 		$242K Sell
1,446
-97
-6% -$16.3K 0.01% 417
2020
Q2 		$251K Sell
1,543
-552
-26% -$98.9K 0.02% 378
2020
Q1 		$362K Buy
2,095
+253
+14% +$50.4K 0.03% 249
2019
Q4 		$370K Buy
1,842
+31
+2% +$6.36K 0.03% 301
2019
Q3 		$383K Buy
1,811
+467
+35% +$97.6K 0.03% 249
2019
Q2 		$261K Buy
1,344
+8
+0.6% +$1.48K 0.02% 309
2019
Q1 		$220K Sell
1,336
-308
-19% -$54.5K 0.02% 368
2018
Q4 		$309K Buy
1,644
+192
+13% +$35.5K 0.03% 249
2018
Q3 		$247K Buy
1,452
+106
+8% +$17.8K 0.03% 359
2018
Q2 		$221K Buy
1,346
+492
+58% +$80.4K 0.02% 381
2018
Q1 		$138K Buy
+854
New +$136K 0.02% 428
2016
Q4 		– Sell
-857
Closed -$90K – 431
2016
Q3 		$90K Buy
857
+504
+143% +$52.6K 0.01% 388
2016
Q2 		$34K Buy
353
+119
+51% +$11.2K 0.01% 566
2016
Q1 		$22K Buy
234
+138
+144% +$12.6K ﹤0.01% 637
2015
Q4 		$9K Buy
96
+22
+30% +$2.07K ﹤0.01% 744
2015
Q3 		$7K Buy
74
+54
+270% +$5.13K ﹤0.01% 749
2015
Q2 		$2K Buy
+20
New +$1.87K ﹤0.01% 874
2014
Q2 		– Sell
-72
Closed -$5K – 896
2014
Q1 		$5K Buy
+72
New +$5.43K ﹤0.01% 518

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SignatureFD's CME Position: Q1 2026 in Review

SignatureFD increased its CME Group (CME) stake by 0.43% in Q1 2026, buying an estimated $8.32K and bringing the position to 6,584 shares worth $1.94M. The position accounts for 0.03% of the portfolio, ranked #239.

SignatureFD first reported a position in CME in Q1 2014 and has held it in 40 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • SignatureFD held 6,584 shares of CME Group worth $1.94M as of Q1 2026.
  • SignatureFD bought 28 CME Group shares in Q1 2026, an estimated $8.32K.
  • CME Group made up 0.03% of SignatureFD's portfolio in Q1 2026, its #239 holding.
  • SignatureFD first reported a position in CME Group in Q1 2014 and has held it in 40 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.